It feels like a lifetime ago now, but it's four years since the final report from Jim O'Neill's Review on AMR was published.
Today in 2016, would we have been happy with the progress that's been made today? (1/)
Today in 2016, would we have been happy with the progress that's been made today? (1/)
We've seen stronger collaboration from the #tripartite, and an increasing recognition of the importance of a #OneHealth approach - even if significant support is still needed to help countries deliver effective national action (2/) https://twitter.com/DrTedros/status/1046742342403846146?s=20
Initiatives like @SEDRICThinkTank, @WHO GLASS and @FlemingFund, plus work funded by @Wellcome_AMR + others are helping address big gaps in global
#surveillance of drug-resistant infections (3/) https://www.who.int/gho/glass/surveillance/en/

We have seen progress with @UN-led processes on #AMR - particularly with IACG recommendations. Big moment just last week as proposals for ToR for independent evidence panel published (4/) https://twitter.com/EdWhiting1/status/1261304165843771392?s=20
But #COVID19 crisis has left us in a precarious position with next steps in @UN discussions on AMR unclear. And @g20org discussions on drug-resistant infections faltering (5/) https://www.linkedin.com/pulse/why-g20-needs-stay-course-drug-resistant-infections-jeremy-knox/?trackingId=5PYRKUEBe4EacnSumdc5Kg%3D%3D
Significantly, big progress being made by @CARB_X, @gardp_amr + @novonordiskfond REPAIR fund to re-vitalise
R&D - particularly early stage. 60 projects now funded by @CARB_X! (6/) https://twitter.com/CARB_X/status/1259914783886848001?s=20

...but still too little progress from governments to decisively fix the broken market for #antibiotics - many small developers in increasingly precarious
state
https://wellcome.ac.uk/sites/default/files/the-growing-crisis-for-antibiotic-r-and-d.pdf (7/)

https://wellcome.ac.uk/sites/default/files/the-growing-crisis-for-antibiotic-r-and-d.pdf (7/)
So overall: big steps, but mixed picture
As Jim O'Neill said in @CHGlobalHealth review of progress in 2019 "unless key players are prepared to... make bolder decisions, the challenge is never going to be solved"
Opportunity for this post-COVID?
(END) https://www.chathamhouse.org/publication/review-progress-antimicrobial-resistance
As Jim O'Neill said in @CHGlobalHealth review of progress in 2019 "unless key players are prepared to... make bolder decisions, the challenge is never going to be solved"
Opportunity for this post-COVID?

Anything I've missed? Anything to add?
@HananBalkhy @hygetahun @koutterson @damidefelice @hboucher3 @Manica_amr @UKAMREnvoy @MirfinM
@HananBalkhy @hygetahun @koutterson @damidefelice @hboucher3 @Manica_amr @UKAMREnvoy @MirfinM